Birkenhäger A M, van den Meiracker A H
Department of Internal Medicine, Vascular Pharmacology, Erasmus Medical Centre, 's Gravendijkwal 230, 3015 GD Rotterdam, The Netherlands.
Neth J Med. 2007 Apr;65(4):127-31.
The development and clinical application of ambulatory blood pressure monitoring (ABP M) has brought several of the main features of the circadian blood pressure (BP) rhythm to light. ABP M has shown to be a very useful method in cardiovascular risk assessment and remains the only method of diagnosing a non-dipping blood pressure profile. A 'non-dipping' BP profile is currently regarded as a risk factor in its own right for cardiovascular (CV) events and target organ damage. Nevertheless, the reliability of ABP M in assessing dipping status is still being questioned. Furthermore, a clear-cut definition of 'non-dipping' has not been established so far. The pathophysiological mechanism(s) of a non-dipping profile might involve abnormalities in extracellular volume and/or vascular resistance regulation. In addition, differences in daytime and nighttime activity, sleep quality and body position during sleep are involved as well. A reduction in cardiovascular risk by a pharmacologically induced switch from a non-dipper to a dipper status might be expected, but remains to be proven.
动态血压监测(ABPM)的发展及临床应用揭示了昼夜血压(BP)节律的几个主要特征。ABPM已被证明是心血管风险评估中非常有用的方法,并且仍然是诊断非勺型血压模式的唯一方法。目前,“非勺型”血压模式本身被视为心血管(CV)事件和靶器官损害的危险因素。然而,ABPM在评估勺型状态方面的可靠性仍受到质疑。此外,迄今为止尚未明确建立“非勺型”的定义。非勺型模式的病理生理机制可能涉及细胞外液量和/或血管阻力调节异常。此外,白天和夜间活动、睡眠质量以及睡眠期间的体位差异也有影响。通过药物诱导从非勺型转变为勺型状态来降低心血管风险是可以预期的,但仍有待证实。